安全专家小组得出结论

职场攻略2025-09-21 20:39:02887

据悉,欧盟2021年4月9日,评估欧盟食品安全局就一种食品酶制剂异麦芽糖合酶(isomaltulose synthase)的种异安全性评价发布意见。

据了解,麦芽酶这种食品酶制剂是糖合由Serratia plymuthica strain Z12A生产的。经过评估,安全专家小组得出结论,欧盟该食品酶制剂在预期的评估使用条件下不会引起安全问题。部分原文报道如下:

The 种异food enzyme isomaltulose synthase (sucrose glucosylmutase; EC 5.4.99.11) is produced with Serratia plymuthica strain Z12A by BENEO‐Palatinit GmbH. The food enzyme is used only in the form of an immobilised preparation of non‐viable cells for the production of isomaltulose. Residual amounts of total organic solids (TOS) are removed by the purification steps applied during the production of isomaltulose consequently, dietary exposure was not calculated. Genotoxicity tests did not indicate safety concern. The systemic toxicity was assessed by means of a repeated dose 90‐day oral toxicity study in rats. The Panel identified a no observed adverse effect level of 1,011 mg TOS/kg body weight (bw) per day, the highest dose tested. Similarity of the amino acid sequence of the enzyme to those of known allergens was searched and no match was found. The Panel considered that, under the intended conditions of use, the risk of allergic sensitisation and elicitation reactions by dietary exposure cannot be excluded, but the likelihood of such reactions to occur is considered to be low. based on the data provided, the use of an immobilised food enzyme and the removal of TOS during the production of isomaltulose the Panel concluded that this food enzyme preparation does not give rise to safety concerns under the intended conditions of use.

资料来源:食品伙伴网。如涉及作品内容、麦芽酶版权等问题,糖合请与本网联系删除。安全

相关链接:异麦芽糖,欧盟食品安全

评估
本文地址:http://bbs.wangaobaowen.com/97a30699596lbtio.html
版权声明

本文仅代表作者观点,不代表本站立场。
本文系作者授权发表,未经许可,不得转载。

全站热门

《中国车手周冠宇》曝终极预告 挑战自我征服速度

保健品与一日三餐:并非对立 而是相辅相成

光伏新政促信心 光伏龙头企业脱困,行业资讯

【新品推荐】肺炎克雷伯菌核酸参考品(热灭活)隆重上新,欢迎抢购!

路阳执导科幻电影《我们生活在南京》首曝海报!

承载万千学子健康  让“小饭桌”成为“放心桌”

罚款15万元!浙江景宁依法查处虚假宣传羊奶粉案

保健品与一日三餐:并非对立 而是相辅相成

友情链接